Steinert Carolin, Pashuk Margarita, Kolkhir Pavel, Kocatürk Emek, Xiang Yi-Kui
Institute of Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Hindenburgdamm 27, 12203, Berlin, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin, Germany.
Curr Allergy Asthma Rep. 2025 Aug 9;25(1):34. doi: 10.1007/s11882-025-01215-8.
This review aims to educate allergists about the concept of autoallergy by addressing five questions: 1) What is autoallergy and how does it differ from classical allergy? 2) How common is autoallergy? 3) Is autoallergy clinically relevant? 4) How can autoallergy be diagnosed? and 5) How is autoallergy treated?
In contrast to type I hypersensitivity against external allergens (allergy), autoallergy involves IgE autoantibodies targeting self-antigens. These are found in conditions like chronic spontaneous urticaria, atopic dermatitis, and asthma, with varying prevalence. While no standardized diagnostic tools exist, ELISA and basophil activation tests help identify the presence and function of IgE autoantibodies. Anti-IgE therapies have shown benefit, supporting their clinical relevance. Autoallergy is emerging as a distinct IgE-mediated mechanism that may contribute to chronic inflammation in immune-mediated diseases. Further investigation of this mechanism can improve disease stratification and enable more effective, targeted treatment strategies.
本综述旨在通过回答五个问题,让过敏症专科医生了解自身过敏的概念:1)什么是自身过敏,它与经典过敏有何不同?2)自身过敏有多常见?3)自身过敏在临床上是否相关?4)如何诊断自身过敏?以及5)如何治疗自身过敏?
与针对外部过敏原的I型超敏反应(过敏)不同,自身过敏涉及靶向自身抗原的IgE自身抗体。这些在慢性自发性荨麻疹、特应性皮炎和哮喘等疾病中存在,患病率各不相同。虽然不存在标准化的诊断工具,但ELISA和嗜碱性粒细胞活化试验有助于识别IgE自身抗体的存在和功能。抗IgE疗法已显示出益处,支持了它们的临床相关性。自身过敏正在成为一种独特的IgE介导机制,可能导致免疫介导疾病中的慢性炎症。对这一机制的进一步研究可以改善疾病分层,并实现更有效、有针对性的治疗策略。